Scientists have developed an advanced light-based biosensor capable of detecting extremely small quantities of cancer biomarkers in blood. This laboratory innovation combines CRISPR technology, DNA nanotechnology, and quantum dots, potentially allowing earlier diagnosis of cancers such as lung cancer through routine blood tests.